ALSV

ATP Life Science Ventures Portfolio holdings

AUM $898M
1-Year Est. Return 84.86%
This Quarter Est. Return
1 Year Est. Return
+84.86%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$1.3B
AUM Growth
+$553M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
3
New
Increased
Reduced
Closed

Top Buys

1
+$63.9M
2
+$23.2M

Top Sells

No sells this quarter

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
STOK icon
1
Stoke Therapeutics
STOK
$1.77B
$1.06B 82.06%
17,161,713
+375,000
AKRO icon
2
Akero Therapeutics
AKRO
$4.32B
$168M 13.01%
5,830,203
KDNY
3
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
$63.9M 4.93%
+4,028,937